These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32668259)

  • 1. CD4
    Greenshields-Watson A; Attaf M; MacLachlan BJ; Whalley T; Rius C; Wall A; Lloyd A; Hughes H; Strange KE; Mason GH; Schauenburg AJ; Hulin-Curtis SL; Geary J; Chen Y; Lauder SN; Smart K; Vijaykrishna D; Grau ML; Shugay M; Andrews R; Dolton G; Rizkallah PJ; Gallimore AM; Sewell AK; Godkin AJ; Cole DK
    Cell Rep; 2020 Jul; 32(2):107885. PubMed ID: 32668259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
    MacLachlan BJ; Dolton G; Papakyriakou A; Greenshields-Watson A; Mason GH; Schauenburg A; Besneux M; Szomolay B; Elliott T; Sewell AK; Gallimore A; Rizkallah P; Cole DK; Godkin A
    J Biol Chem; 2019 Dec; 294(52):20246-20258. PubMed ID: 31619516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence and Structural Analyses Reveal Distinct and Highly Diverse Human CD8
    Chen G; Yang X; Ko A; Sun X; Gao M; Zhang Y; Shi A; Mariuzza RA; Weng NP
    Cell Rep; 2017 Apr; 19(3):569-583. PubMed ID: 28423320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad TCR repertoire and diverse structural solutions for recognition of an immunodominant CD8
    Song I; Gil A; Mishra R; Ghersi D; Selin LK; Stern LJ
    Nat Struct Mol Biol; 2017 Apr; 24(4):395-406. PubMed ID: 28250417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide.
    Carreno BM; Turner RV; Biddison WE; Coligan JE
    J Immunol; 1992 Feb; 148(3):894-9. PubMed ID: 1370522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A targeted single mutation in influenza A virus universal epitope transforms immunogenicity and protective immunity via CD4
    Hulin-Curtis S; Geary JK; MacLachlan BJ; Altmann DM; Baillon L; Cole DK; Greenshields-Watson A; Hesketh SJ; Humphreys IR; Jones IM; Lauder SN; Mason GH; Smart K; Scourfield DO; Scott J; Sukhova K; Stanton RJ; Wall A; Rizkallah PJ; Barclay WS; Gallimore A; Godkin A
    Cell Rep; 2024 Jun; 43(6):114259. PubMed ID: 38819988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytotoxic CD4+ T cells recognize HLA-DR1-restricted epitopes on vaccinia virus proteins A24R and D1R conserved among poxviruses.
    Mitra-Kaushik S; Cruz J; Stern LJ; Ennis FA; Terajima M
    J Immunol; 2007 Jul; 179(2):1303-12. PubMed ID: 17617623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I binding 9mer peptides from influenza A virus induce CD4 T cell responses.
    Wang M; Larsen MV; Nielsen M; Harndahl M; Justesen S; Dziegiel MH; Buus S; Tang ST; Lund O; Claesson MH
    PLoS One; 2010 May; 5(5):e10533. PubMed ID: 20479886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses.
    Grant E; Wu C; Chan KF; Eckle S; Bharadwaj M; Zou QM; Kedzierska K; Chen W
    Immunol Cell Biol; 2013 Feb; 91(2):184-94. PubMed ID: 23399741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six unrelated HLA-DR-matched adults recognize identical CD4+ T cell epitopes from influenza A haemagglutinin that are not simply peptides with high HLA-DR binding affinities.
    Gelder C; Davenport M; Barnardo M; Bourne T; Lamb J; Askonas B; Hill A; Welsh K
    Int Immunol; 1998 Feb; 10(2):211-22. PubMed ID: 9533449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A reductionist cell-free major histocompatibility complex class II antigen processing system identifies immunodominant epitopes.
    Hartman IZ; Kim A; Cotter RJ; Walter K; Dalai SK; Boronina T; Griffith W; Lanar DE; Schwenk R; Krzych U; Cole RN; Sadegh-Nasseri S
    Nat Med; 2010 Nov; 16(11):1333-40. PubMed ID: 21037588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ADAMTS13
    Gilardin L; Delignat S; Peyron I; Ing M; Lone YC; Gangadharan B; Michard B; Kherabi Y; Sharma M; Pashov A; Latouche JB; Hamieh M; Toutirais O; Loiseau P; Galicier L; Veyradier A; Kaveri S; Maillère B; Coppo P; Lacroix-Desmazes S
    Haematologica; 2017 Nov; 102(11):1833-1841. PubMed ID: 28751567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass tag-assisted identification of naturally processed HLA class II-presented meningococcal peptides recognized by CD4+ T lymphocytes.
    Meiring HD; Kuipers B; van Gaans-van den Brink JA; Poelen MC; Timmermans H; Baart G; Brugghe H; van Schie J; Boog CJ; de Jong AP; van Els CA
    J Immunol; 2005 May; 174(9):5636-43. PubMed ID: 15843563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with recombinant NY-ESO-1 protein elicits immunodominant HLA-DR52b-restricted CD4+ T cell responses with a conserved T cell receptor repertoire.
    Bioley G; Dousset C; Yeh A; Dupont B; Bhardwaj N; Mears G; Old LJ; Ayyoub M; Valmori D
    Clin Cancer Res; 2009 Jul; 15(13):4467-74. PubMed ID: 19531622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopeptidomic analysis of influenza A virus infected human tissues identifies internal proteins as a rich source of HLA ligands.
    Nicholas B; Bailey A; Staples KJ; Wilkinson T; Elliott T; Skipp P
    PLoS Pathog; 2022 Jan; 18(1):e1009894. PubMed ID: 35051231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Simple Proteomics-Based Approach to Identification of Immunodominant Antigens from a Complex Pathogen: Application to the CD4 T Cell Response against Human Herpesvirus 6B.
    Becerra-Artiles A; Dominguez-Amorocho O; Stern LJ; Calvo-Calle JM
    PLoS One; 2015; 10(11):e0142871. PubMed ID: 26599878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly divergent T-cell receptor binding modes underlie specific recognition of a bulged viral peptide bound to a human leukocyte antigen class I molecule.
    Liu YC; Miles JJ; Neller MA; Gostick E; Price DA; Purcell AW; McCluskey J; Burrows SR; Rossjohn J; Gras S
    J Biol Chem; 2013 May; 288(22):15442-54. PubMed ID: 23569211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites.
    Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I
    Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccinia peptides eluted from HLA-DR1 isolated from virus-infected cells are recognized by CD4+ T cells from a vaccinated donor.
    Strug I; Calvo-Calle JM; Green KM; Cruz J; Ennis FA; Evans JE; Stern LJ
    J Proteome Res; 2008 Jul; 7(7):2703-11. PubMed ID: 18507432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.
    Richards KA; Chaves FA; Krafcik FR; Topham DJ; Lazarski CA; Sant AJ
    J Virol; 2007 Jul; 81(14):7608-19. PubMed ID: 17507491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.